Promising therapies to combat the coronavirus include Gilead’s remdesivir, the generic steroid dexamethasone, and therapies that use plasma from people who have recovered from the virus, according to a list distributed by the HHS Dept.
- Scientists are also studying whether monoclonal antibodies, hyperimmune globulin and heparin are effective against Covid-19
- List doesn’t include hydroxychloroquine, which President Trump as recently as last week touted as a potential treatment despite multiple warnings of dangerous side effects from health officials and the FDA
- NOTE: FDA revoked Emergency Use Authorization for hydroxychloroquine in June
- Related:
Gilead Says Remdesivir Linked to a Reduction in Mortality ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.